Regen is focused on identifying undervalued regenerative medicine applications in the stem cell/immunotherapy space and rapidly advancing these technologies through pre clinical and Phase I/II clinical trials. Currently the Company is developing products treating blood disorders using small molecules and gene silencing DiffronC , treating cancer with immunotherapy dCellVax , modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches BORIS , and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients HemaXellerate .
Quote | Regen BioPharma (OTCMKTS:RGBPP)
Last: | $0.25005 |
---|---|
Change Percent: | 0.0% |
Open: | $0.2 |
Close: | $0.25005 |
High: | $0.25005 |
Low: | $0.1999 |
Volume: | 6,876 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Regen BioPharma (OTCMKTS:RGBPP)
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments PR Newswire SAN DIEGO , Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing sev...
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program PR Newswire SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of its DuraCAR CAR T-cell therapeutic ( http...
Message Board Posts | Regen BioPharma (OTCMKTS:RGBPP)
Subject | By | Source | When |
---|---|---|---|
That is a funny buy at 10.00 Koos | bigtalan | investorshub | 03/16/2023 4:31:15 PM |
Yeap even a bigger spread but noone is | bigtalan | investorshub | 03/15/2023 1:43:37 PM |
Helluva spread | art35 | investorshub | 03/10/2023 5:44:52 PM |
Are you adding? Went on sale today again. | SidVicious | investorshub | 03/09/2023 1:30:53 AM |
Definitely rgBAD! | SidVicious | investorshub | 03/09/2023 1:30:09 AM |
News, Short Squeeze, Breakout and More Instantly...
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments PR Newswire SAN DIEGO , Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing sev...
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program PR Newswire SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of its DuraCAR CAR T-cell therapeutic ( http...
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program PR Newswire Autoimmunity to be Targeted SAN DIEGO , Oct. 25, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) ...